Unsupervised Learning Approaches for Identifying ICU Patient Subgroups: Do Results Generalise?
The use of unsupervised learning to identify patient subgroups has emerged as a potentially promising direction to improve the efficiency of Intensive Care Units (ICUs). By identifying subgroups of patients with similar levels of medical resource need, ICUs could be restructured into a collection of smaller subunits, each catering to a specific group. However, it is unclear whether common patient subgroups exist across different ICUs, which would determine whether ICU restructuring could be operationalised in a standardised manner. In this paper, we tested the hypothesis that common ICU patient subgroups exist by examining whether the results from one existing study generalise to a different dataset. We extracted 16 features representing medical resource need and used consensus clustering to derive patient subgroups, replicating the previous study. We found limited similarities between our results and those of the previous study, providing evidence against the hypothesis. Our findings imply that there is significant variation between ICUs; thus, a standardised restructuring approach is unlikely to be appropriate. Instead, potential efficiency gains might be greater when the number and nature of the subunits are tailored to each ICU individually.
Code (1)
Similar Papers 제목 키워드 기반
Unsupervised Machine Learning for the Discovery of Latent Disease Clusters and Patient Subgroups Using Electronic Health Records
Machine learning has become ubiquitous and a key technology on mining electronic health records (EHRs) for facilitating clinical research and practice. Unsupervised machine learning, as opposed to supervised learning, ha…
BIG-bench Machine LearningEpidemiologySurvival AnalysisIdentifying treatment response subgroups in observational time-to-event data
Identifying patient subgroups with different treatment responses is an important task to inform medical recommendations, guidelines, and the design of future clinical trials. Existing approaches for treatment effect esti…
A Deep Subgrouping Framework for Precision Drug Repurposing via Emulating Clinical Trials on Real-world Patient Data
Drug repurposing identifies new therapeutic uses for existing drugs, reducing the time and costs compared to traditional de novo drug discovery. Most existing drug repurposing studies using real-world patient data often …
Drug DiscoveryUnsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence
Risk stratification is a key tool in clinical decision-making, yet current approaches often fail to translate sophisticated survival analysis into actionable clinical criteria. We present a novel method for unsupervised …
Decision MakingExplainable artificial intelligenceSurvival AnalysisFederated unsupervised random forest for privacy-preserving patient stratification
In the realm of precision medicine, effective patient stratification and disease subtyping demand innovative methodologies tailored for multi-omics data. Clustering techniques applied to multi-omics data have become inst…
ClusteringFeature ImportancePrivacy Preserving